Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo
The company’s largest center for medical device applications, serving the entire Asian market
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
Xtandi is approved in over 80 countries, including the U.S., EU, and Japan
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
Addresses brain metastases harboring BRCA1/2 and/or HRR alterations—an area of high unmet need
ART-123 is a recombinant human thrombomodulin approved in Japan in 2008
InnoCell is the brand name for Mitsui Chemicals’ cell culture products and services
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
The approval is based on a comprehensive package of analytical, nonclinical, and clinical data
Subscribe To Our Newsletter & Stay Updated
